Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Journal of Practical Hepatology》 2014-01
Add to Favorite Get Latest Update

Efficacy of co mpound embryonic bovine liver extract tablets in treatment of patients with chronic hepatitis B

Sun Tao;Mao Hua;Wang Qian;Department of Digestive Diseases,Southern Medical University;  
Objective To observe the efficacy of compound embryonic bovine liver extract tablets in treatment of patients with chronic hepatitis B(CHB). Methods One hundred and twenty patients with CHB were recruited,and divided randomly into control group(n=56)or treatment group(n=64);Patients in control group were treated with basic liver-protecting treatment and patients in treatment group were treated with combinational therapy of compound embryonic bovine liver extract tablets and basic treatment. Changes in liver function tests and fibrotic parameters were examed after 3 months of treatment. Results At the end of 3 months of treatment,the fatigue and poor appetite were improved in 92.00% and 91.84%,respectively,in treatment group,significantly higher than those in controls(56.41% and 58.33%,respectively,P0.05);the serum ALT,AST,GGT and total bilirubin levels in treatment group were(35.6±17.2) U/L,(38.5±18.6) U/L,(40.6±19.7) U/L and(16.1±13.9) μmol/L, respectively,significantly decreased than those before treatment [(110.8±61.4) U/L for ALT,(97.2±62.4) U/L for AST,(106.3±60.1) U/L for GGT and(47.8±19.3) μmol/L for total bilirubin,P0.05];serum PIIIP(36.7±11.3 μg/ L),HA(276.4±79.5 μg/L),LN(169.8±73.4 μg/L) and IV-C(155.8±61.5 μg/L) in treatment group decreased significantly than those before treatment [(16.4±6.1) μg/L for PIIIP,(110.8±51.4) μg/L for HA,(70.8±34.9) μg/L for LN and(97.8 ±41.4) μg/L for IV-C,P 0.05],which lowered more obviously than in control. Conclusion Compound embryonic bovine liver extract may be a promising therapeutic remedy for patients with CHB.
【CateGory Index】: R512.62
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 5 Hits
1 HU Xiya,WANG Luwen,MA Jinchun,et al. Department of Infectious Diseases,Huangshi Aikang Hospital,Huangshi 435000,Hubei,China;Effects of embryonic bovine liver extract compound on hepatic fibrosis in patients with chronic hepatitis B[J];Journal of Clinical Hepatology;2010-01
2 LI Xiaoling,LUO Xiaoke,LI Zhaoxin,et al.Department of Infectious Disease,313rd Hospital of PLA,Huludao 125000,Liaoning Province,China;Analysis of pathological diagnosis of percutaneous liver biopsy in 71 patients with chronic hepatitis B[J];Journal of Clinical Hepatology;2011-02
3 CHENG Shi(Contagious Hospital of Liaoyang,Liaoyang 111000 China);The Therapeutic Effect Analysis of the Chronic Type B Hepatitis(CHB) by Combining Kushenin and Complex Prescription Cattle Liver Extractive Pellet[J];Journal of Liaoning Medical University;2008-02
4 HE Lu-fu(903 hospital of Jiangyou,Sichuan 621700,China);Clinical research on the treatment of hepatic fibrosis in chronic hepatitis B by combined use of lamivudine and An-Fa-Te[J];Modern Medicine & Health;2008-10
5 HE Xiao,XU Hai-fan.(Department of Tumor Surgery,the First Affiliated Hospital of Nanhua University,Hengyang 421001,China);Research Progress in Treatment of Liver Fibrosis[J];Medical Recapitulate;2009-23
【Co-citations】
Chinese Journal Full-text Database 10 Hits
1 ZHENG Chong,HUANG Bao-ru,WANG Peng*,CHEN Le-wu,XIE Yun-zheng Department of Infectious Diseases,The First People's Hospital of Shunde District,Foshan,Guangdong 528300,China;Therapeutic efficacy of combination treatment with compound Biejiaruangan tablet and pegylated interferon α-2a for chronic hepatitis B[J];Infectious Disease Information;2012-02
2 Zheng Chong,Huang Baoru,Wang Peng,et al.Department of Infectious Disease,First People's Hospital,Foshan 528300,Guangdong Province,China;Efficacy of combined therapy of compound embryonic bovine liver extract and adefovir dipivoxil on patients with chronic hepatitis B[J];Journal of Clinical Hepatology;2012-05
3 LIANG Jing MO Xiaoping Department of Infectious Diseases,the People's Hospital of Huaiji County in Guangdong Province,Huaiji 526400,China;Early clinical observation of entecavir dispersible tablets on the treatment of chronic hepatitis B[J];China Medicine and Pharmacy;2012-20
4 YU Liyou;WANG Longde;ZHANG Jing;LIU Junhong;Affiliated Hospital to Gansu University of Traditional Chinese Medicine;;Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J];Western Journal of Traditional Chinese Medicine;2013-10
5 DENG Qiu-ju;PAN Ya-qi;WANG Chao-yi;LI Feng-lei;LV Shao-jiang;HU Shao-yong;NING Tao;GUO Chuan-hai;HE Zhong-hu;KE Yang;Key Laboratory of Carcinogenesis and Translational Research,Ministry of Education; Laboratory of Genetics,Peking University Cancer Hospital & Institute;Hua County Bureau of Health,Henan Province;Hua County People’s Hospital,Henan Province;;Prevalence and risk factors for hepatitis B in Hua County,Henan Province[J];Journal of Peking University(Health Sciences);2013-06
6 ZENG Jingfeng;ZHENG Xin;XIONG Wen;CHEN Yunlong;ZENG Xuezhen;ShenZhen blood center;;Study on the HBV DNA presence from HBsAg-/NAT+/HBV DNA-donors screened by nucleic acid test[J];Chinese Journal of Blood Transfusion;2013-12
7 ZHU Weigang;ZHENG Xin;YE Xianlin;ZHAGN Hong;XIONG Wen;ZENG Jinfeng;ShenZhen Blood Center;;The molecular characterization of HBV infection in the hepatitis B vaccinated blood donors from Shenzhen area[J];Chinese Journal of Blood Transfusion;2013-10
8 XIA Xu-hui;CHEN Xin;Department of Infectious Diseases,The First People's Hospital of Neijiang;;Retrospective analysis of the effect of nucleoside analogues on HBV reactivation due to glucocorticoid therapy[J];Infectious Disease Information;2013-06
9 ZHANG Min-feng;QIAN Pei-xin;PU Rui;HAN Xue;ZHANG Hong-wei;YANG Jia-mei;YIN Jian-hua;Department of Special Treatment,Eastern Hepatobiliary Hospital,Second Military Medical University;Department of Clinical Diagnosis,The First People's Hospital of Zhangjiagang;Department of Epidemiology,Second Military Medical University;Center for Disease Control and Prevention of Yangpu District;;Frequencies and risk of basic core promoter region mutations of HBV in HBV-related liver diseases[J];Academic Journal of Second Military Medical University;2013-09
10 Qing-wei Gao;De-sheng Yuan;Dalian Sixth People’s Hospital;;Clinical Characteristics and Treatment for Patients with Occult Chronic Hepatitis B[J];国际感染杂志(电子版)(英文版);2013-01
China Proceedings of conference Full-text Database 1 Hits
1 LIANG Jian,SHAO Xiao-ping,WU Cheng-gang,ZHAO Zhan-jie,ZHANG Ji-kai,LIU Yu,Center for Disease Control and Prevention of Guangdong Province,Guangzhou 510300,China.;Changes of the Prevalence of Hepatitis B Virus Surface Antigen in Guangdong Province[A];[C];2013
【Secondary Citations】
Chinese Journal Full-text Database 10 Hits
1 Cai Xiong; Wang Guojun; Qu Yao; Fan Chenghui; Zhang Ruiqi; Xu Wensheng (Department of Infectious Diseases, Changzheng Hospital, Second Military Medical University,Shanghai, 200003);Clinical efficacy of kurorinone in the treatment of chronic hepatitis B[J];Academic Journal of Second Military Medical University;1997-01
2 ZHANG Rong-hua, ZHOU Zi-cheng, HONG Duo-lun, AI Jiu-song (Department of Traditional Chinese Medicine, Southwest Hospital, Third Military Medical University, Chongqing 400038,China);Effects of Panax Notogenseng on CCl4-induced liver fibrosis in rats[J];ACTA ACADEMIAE MEDICINE MILITARIS TERTIAE;2000-04
3 Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association.;Guidelines for diagnosis and treatment of alcoholic liver diseases[J];Journal of Clinical Hepatology;2007-01
4 LI Yi,ZHU Chuanlong,GAO Rentao,et al.Department of Infectious Disease,Affiliated Provincial Hospital,Anhui Medical University,Hefei 230001,China;The serum level of TIMP-2 in diagnosing hepatic fibrosis in patients with hepatitis B viral infection[J];Journal of Clinical Hepatology;2009-01
5 Zhou Guangde, Li Wenshu, Zhao Jingmin et al. 302 Hospital of PLA, Beijing 100039, China;Clinical pathological study on the mechanism of effect of Fufangbiejiaruanganpian in treatment of liver fibrosis[J];Medical Journal of Chinese People's Liberation Army;2004-07
6 Zhao Jingmin,Zhou Guangde,Sun Yanling,et al.Department of Pathology,302 Hospital of PLA,Beijing 100039,China;Pathological,epidemiological and prognostic studies in 25946 patients with liver disease with liver needle biopsy[J];Medical Journal of Chinese People's Liberation Army;2008-10
7 GU ZHU-ying, WENG Hong-lei, CAI Wei-min,et al ( First Hospital Affiliated to Zhejiang University School of Medicine,HangZhou 310003);Study on clinical value of serum parameters of liver fibrosis in chronic viral hepatitis[J];CHINESE JOURNAL OF CLINICAL HEPATOLOGY;2000-03
8 WANG Xiao-Feng~1,DONG Pei-Hong~2,CHEN Wei~1,et al.(1.The Third Affiliated Hospital,Wenzhou Medical College,Wenzhou 325200,China;2.The First Affiliated Hospital,Wenzhou Medical College,Wenzhou 325000);Effect of tetrandrine on rat hepatic stellate cells stimulated by lipopolysaccharide[J];Modern Practical Medicine;2006-07
9 Xu Lihong,Zheng Yong,Li Rui,Sun Kan,Chang Xiangyun,Chen Weigang,Chen Ying(Department of Digestology,The First Affiliated Hospital of Shihezi University School of medicine,Shihezi 832008,XingJiang,China);Effects of antisense TβRI eukaryotic expressing plasmid on rat liver fibrosis[J];Journal of Nongken Medicine;2007-01
10 YOU Hong*,WU Xiao-ning,WANG Qian-yi,WU Peng,CONG Rui,YANG Ai-ting,OU Xiao-juan,MA Hong,ZHANG Fu-kui,WANG Bao-en,JIA Ji-dong(Liver Research Center,Beijing Friendship Hospital,Capital Medical University);Two-year Efficacy of Entecavir for the Treatment of Chronic Hepatitis B,Compensated and Decompensated Cirrhosis[J];Journal of Capital Medical University;2010-05
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved